Relationship among α-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra

被引:74
作者
Mori, Fumiaki
Nishie, Makoto
Kakita, Akiyoshi
Yoshimoto, Makoto
Takahashi, Hitosh
Wakabayashi, Koichi
机构
[1] CSIC, IIBB, Consejo Super Invest Cinetif Rossello, Inst Invest Biomed Barcelona,Dept Neuroquim, Barcelona 08036, Spain
[2] Niigata Univ, Brain Res Inst, Dept Pathol, Niigata 95021, Japan
[3] Niigata Univ, Brain Res Inst, Dept Pathol Neurosci, Niigata 95021, Japan
[4] Taisho Pharmceut, Med Res Lab, Mol Biol Lab, Saitama, Japan
[5] Hirosaki Univ, Sch Med, Inst Brain Sci, Dept Neuropathol, Hirosaki, Aomori, Japan
关键词
alpha-synuclein; neuromelanin; neuronal cell death; Parkinson disease; substantia nigra; tyrosine hydroxylase;
D O I
10.1097/01.jnen.0000230520.47768.1a
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The histologic hallmark of Parkinson disease (PD) is loss of pigmented neurons in the substantia nigra (SN) and locus ceruleus (LC) with accumulation of a-synuclein (alpha S). It has been reported that tyrosine hydroxylase (TH)-negative pigmented neurons are present in these nuclei of patients with PD. However, the relationship between TH immunoreactivity and as accumulation remains uncertain. We immunohistochernically examined the SN and LC from patients with PD (n = 10) and control subjects (n = 7). A correlation study indicated a close relationship among decreased TH immunoreactivity, US accumulation, and neuronal loss. In addition, 10% of pigmented neu4. tons in the SN and 54.9% of those in the LC contained abnormal US aggregates. Moreover, 82.3% of pigmented neurons bearing as aggregates in the SN and 39.2% of those in the LC lacked TH immunoreactivity, suggesting that pigmented neurons in the SN have a greater tendency to lack TH activity than those in the LC. Recent studies have shown that this decrease of TH activity leads to a decrease of cytotoxic substances and that decreased dopamine synthesis leads to a reduction of cytotoxic alpha S oligomers. Therefore, the decrease of TH immunoreactivity in pigmented neurons demonstrated here can be considered to represent a cytoprotective mechanism in PD.
引用
收藏
页码:808 / 815
页数:8
相关论文
共 42 条
[11]   Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein [J].
Giasson, BI ;
Duda, JE ;
Quinn, SM ;
Zhang, B ;
Trojanowski, JQ ;
Lee, VMY .
NEURON, 2002, 34 (04) :521-533
[12]   NEURONAL INCLUSIONS OF PARKINSONS-DISEASE [J].
GIBB, WRG ;
SCOTT, T ;
LEES, AJ .
MOVEMENT DISORDERS, 1991, 6 (01) :2-11
[13]   NEW PATHOLOGICAL OBSERVATIONS IN JUVENILE ONSET PARKINSONISM WITH DYSTONIA [J].
GIBB, WRG ;
NARABAYASHI, H ;
YOKOCHI, M ;
IIZUKA, R ;
LEES, AJ .
NEUROLOGY, 1991, 41 (06) :820-822
[14]   ANATOMY, PIGMENTATION, VENTRAL AND DORSAL SUBPOPULATIONS OF THE SUBSTANTIA-NIGRA, AND DIFFERENTIAL CELL-DEATH IN PARKINSONS-DISEASE [J].
GIBB, WRG ;
LEES, AJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1991, 54 (05) :388-396
[15]   Motor dysfunction and gliosis with preserved dopaminergic markers in human α-synuclein A30P transgenic mice [J].
Gomez-Isla, T ;
Irizarry, MC ;
Mariash, A ;
Cheung, B ;
Soto, O ;
Schrump, S ;
Sondel, J ;
Kotilinek, L ;
Day, J ;
Schwarzschild, MA ;
Cha, JHJ ;
Newell, K ;
Miller, DW ;
Uéda, K ;
Young, AB ;
Hyman, BT ;
Ashe, KH .
NEUROBIOLOGY OF AGING, 2003, 24 (02) :245-258
[16]   Accelerated α-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells [J].
Hasegawa, T ;
Matsuzaki, M ;
Takeda, A ;
Kikuchi, A ;
Akita, H ;
Perry, G ;
Smith, MA ;
Itoyama, Y .
BRAIN RESEARCH, 2004, 1013 (01) :51-59
[17]  
Hashimoto M, 2003, ANN NY ACAD SCI, V991, P171
[18]   MELANIZED DOPAMINERGIC-NEURONS ARE DIFFERENTIALLY SUSCEPTIBLE TO DEGENERATION IN PARKINSONS-DISEASE [J].
HIRSCH, E ;
GRAYBIEL, AM ;
AGID, YA .
NATURE, 1988, 334 (6180) :345-348
[19]   THE DISTRIBUTION OF LEWY BODIES IN THE CENTRAL AND AUTONOMIC NERVOUS SYSTEMS IN IDIOPATHIC PARALYSIS AGITANS [J].
JAGER, WAD ;
BETHLEM, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (04) :283-290
[20]   Involvement of Onuf's nucleus in amyotrophic lateral sclerosis [J].
Kihira, T ;
Yoshida, S ;
Yoshimasu, F ;
Wakayama, I ;
Yase, Y .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 147 (01) :81-88